Find More Contacts for ADC Therapeutics
Protected Content
Chief Medical Officer, Health Professional, Senior VP
Non-Management, Executive Management, Operations
3 emails found 2 phone numbers found
View contacts for ADC Therapeutics to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@adctherapeutics.com
  • Phone Number +1 908-731-5556

ADC Therapeutics is a clinical-stage oncology drug discovery and development company focused on advancing highly potent and targeted antibody-drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. Their ADCs are developed using the latest-generation pyrrolobenzodiazepine (PBD) dimer technology providing a superior

therapeutic index compared to first-generation PBD ADCs in preclinical studies. PBD dimers are very potent toxins that actively kill cancer cells and have a differentiated mechanism of action than warheads commonly used in other ADCs.

Lists Featuring This Company

Europe Companies (Top 10K)
9,816 Number of Organizations â€¢ $1.3T Total Funding Amount â€¢ 60,487 Number of Investors
Europe Companies With Less Than $50M in Revenue (Top 10K)
9,849 Number of Organizations â€¢ $434.8B Total Funding Amount â€¢ 55,891 Number of Investors
Europe, Middle East, and Africa (EMEA) Companies With More Than 100 Employees (Top 10K)
9,994 Number of Organizations â€¢ $1.4T Total Funding Amount â€¢ 29,183 Number of Investors
Europe, Middle East, and Africa (EMEA) Companies that Exited (Top 10K)
9,898 Number of Organizations â€¢ $921.8B Total Funding Amount â€¢ 22,386 Number of Investors

Frequently Asked Questions

Where is ADC Therapeutics's headquarters? ADC Therapeutics is located in Lausanne, Vaud, Switzerland.Who invested in ADC Therapeutics? ADC Therapeutics has 7 investors including Deerfield and Deerfield.How much funding has ADC Therapeutics raised to date? ADC Therapeutics has raised .When was the last funding round for ADC Therapeutics? ADC Therapeutics closed its last funding round on Feb 2, 2023 from a Post-IPO Equity round.Who are ADC Therapeutics's competitors? Alternatives and possible competitors to ADC Therapeutics may include C4 Therapeutics and KSQ Therapeutics.